CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData Read more
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData Read more
Alvotech’s AVT05 emerges as leading contender for Simponi biosimilar in rheumatoid arthritis: GlobalData Read more
Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and inflammation targets Read more
Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData Read more
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData Read more